Diffuse Intrinsic Pontine Glioma

Showing 1 - 25 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

    Not yet recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
    • SC-CAR4BRAIN
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 3, 2023

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • Etoposide; Oral, 50 Mg
    • Focused ultrasound with neuro-navigator-controlled sonication
    • New York, New York
      Columbia University Irving Medical Center
    Feb 28, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

    Recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Biopsy
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Feb 2, 2023

    Radiation Therapy in Pediatric Central Nervous System Tumors

    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

      Active, not recruiting
      • Malignant Glioma
      • +2 more
      • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
      • Concurrent Optune and RT followed by Optune System alone
      • Los Angeles, California
      • +8 more
      Jan 17, 2023

      Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

      Completed
      • Diffuse Intrinsic Pontine Glioma
      • +6 more
      • Washington, District of Columbia
      • +6 more
      Jan 12, 2023

      Diffuse Intrinsic Pontine Glioma Trial in Phoenix, San Francisco, Washington (SONALA-001 (ALA) and MR-Guided Focused Ultrasound

      Recruiting
      • Diffuse Intrinsic Pontine Glioma
      • SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
      • Phoenix, Arizona
      • +2 more
      Jan 4, 2023

      Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

      Recruiting
      • Refractory Cancer
      • +10 more
      • Aurora, Colorado
      • +7 more
      Dec 31, 2022

      CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

      Recruiting
      • Central Nervous System Tumor
      • +10 more
      • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

      Recruiting
      • Diffuse Intrinsic Pontine Glioma
      • Diffuse Midline Glioma, H3 K27M-Mutant
      • rHSC-DIPGVax
      • +2 more
      • Orange, California
      • +2 more
      Nov 10, 2022

      Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

      Recruiting
      • Diffuse Intrinsic Pontine Glioma
      • Medulloblastoma, Childhood, Recurrent
      • AloCELYVIR
      • Madrid, Spain
        Hospital Infantil Universitario Niño Jesús
      Sep 29, 2022

      Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

      Active, not recruiting
      • Childhood Astrocytoma
      • +9 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      Sep 8, 2022

      Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

      Recruiting
      • Ewing Sarcoma
      • +6 more
      • Birmingham, Alabama
      • +83 more
      Aug 19, 2022

      Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

      Active, not recruiting
      • Diffuse Intrinsic Pontine Glioma
      • +4 more
      • Los Angeles, California
      • +18 more
      Aug 16, 2022

      High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

      Recruiting
      • High Grade Glioma
      • Diffuse Intrinsic Pontine Glioma
      • Aurora, Colorado
      • +17 more
      Aug 10, 2022

      Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

      Not yet recruiting
      • Diffuse Intrinsic Pontine Glioma
      • Diffuse Midline Glioma, H3 K27M-Mutant
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Jul 27, 2022

      Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

      Recruiting
      • Diffuse Intrinsic Pontine Glioma
      • Histone H3.3-K27M Neoantigen Vaccine Therapy
      • Beijing, Beijing, China
        Beijing Tiantan Hospital, Capital Medical University
      Jul 18, 2022

      Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

      Recruiting
      • Medulloblastoma
      • +7 more
      • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
      • +2 more
      • Buffalo, New York
      • +2 more
      Jul 8, 2022

      Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

      Active, not recruiting
      • Diffuse Intrinsic Pontine Glioma
      • Radiation Therapy
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 5, 2022